Venus Medtech-B (02500) Sets 31 March 2026 Board Meeting to Approve FY 2025 Results

Bulletin Express

03/19

Venus Medtech (Hangzhou) Inc. (stock code: 02500) has announced that its Board of Directors will convene on 31 March 2026. The meeting’s primary agenda is to review and approve the consolidated annual results for the financial year ended 31 December 2025, followed by the publication of the audited figures.

The session will also address any additional corporate matters deemed necessary. According to the disclosure, the company’s current board comprises three executive directors (Lim Hou-Sen, Liqiao Ma and Meirong Liu), two non-executive directors (Ao Zhang and Wei Wang) and three independent non-executive directors (Ting Yuk Anthony Wu, Chi Wai Suen and John Junhua Gu).

The announcement was authorised for issue by Executive Director Mr Lim Hou-Sen on 19 March 2026 in Hangzhou. No further financial details were provided ahead of the scheduled meeting.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1130710402"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1130710402\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1130710402?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-19 19:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1130710402","market":"us","top_or_hot":-1,"title":"Venus Medtech-B (02500) Sets 31 March 2026 Board Meeting to Approve FY 2025 Results","media":"Bulletin Express","content":"<p>Venus Medtech (Hangzhou) Inc. (stock code: 02500) has announced that its Board of Directors will convene on 31 March 2026. The meeting’s primary agenda is to review and approve the consolidated annual results for the financial year ended 31 December 2025, followed by the publication of the audited figures.</p>\n<p>The session will also address any additional corporate matters deemed necessary. According to the disclosure, the company’s current board comprises three executive directors (Lim Hou-Sen, Liqiao Ma and Meirong Liu), two non-executive directors (Ao Zhang and Wei Wang) and three independent non-executive directors (Ting Yuk Anthony Wu, Chi Wai Suen and John Junhua Gu).</p>\n<p>The announcement was authorised for issue by Executive Director Mr Lim Hou-Sen on 19 March 2026 in Hangzhou. No further financial details were provided ahead of the scheduled meeting.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Venus Medtech-B (02500) Sets 31 March 2026 Board Meeting to Approve FY 2025 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVenus Medtech-B (02500) Sets 31 March 2026 Board Meeting to Approve FY 2025 Results\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-03-19 19:22</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Venus Medtech (Hangzhou) Inc. (stock code: 02500) has announced that its Board of Directors will convene on 31 March 2026. The meeting’s primary agenda is to review and approve the consolidated annual results for the financial year ended 31 December 2025, followed by the publication of the audited figures.</p>\n<p>The session will also address any additional corporate matters deemed necessary. According to the disclosure, the company’s current board comprises three executive directors (Lim Hou-Sen, Liqiao Ma and Meirong Liu), two non-executive directors (Ao Zhang and Wei Wang) and three independent non-executive directors (Ting Yuk Anthony Wu, Chi Wai Suen and John Junhua Gu).</p>\n<p>The announcement was authorised for issue by Executive Director Mr Lim Hou-Sen on 19 March 2026 in Hangzhou. No further financial details were provided ahead of the scheduled meeting.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02500","symbol_name":"啓明醫療-B","start_time":0,"source_url":"","article_id":"1130710402","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1130710402","pubTimestamp":1773919343,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Venus Medtech (Hangzhou) Inc. (stock code: 02500) has announced that its Board of Directors will convene on 31 March 2026. The meeting’s primary agenda is to review and approve the consolidated...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02500":"启明医疗-B"},"translate_title":"Venus Medtech-B(02500)定于2026年3月31日召开董事会批准2025财年业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02500":1},"content_text":"Venus Medtech (Hangzhou) Inc. (stock code: 02500) has announced that its Board of Directors will convene on 31 March 2026. The meeting’s primary agenda is to review and approve the consolidated annual results for the financial year ended 31 December 2025, followed by the publication of the audited figures.\nThe session will also address any additional corporate matters deemed necessary. According to the disclosure, the company’s current board comprises three executive directors (Lim Hou-Sen, Liqiao Ma and Meirong Liu), two non-executive directors (Ao Zhang and Wei Wang) and three independent non-executive directors (Ting Yuk Anthony Wu, Chi Wai Suen and John Junhua Gu).\nThe announcement was authorised for issue by Executive Director Mr Lim Hou-Sen on 19 March 2026 in Hangzhou. No further financial details were provided ahead of the scheduled meeting.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}